What is it about?
Cancer-related fatigue (CRF) significantly impacts cancer survivors' physical activity and quality of life and plays a crucial role in treatment decisions. Accurate CRF assessment can be challenging due to patient and provider factors, such as limited clinic time, reporting biases, and the limitations of current measurement tools. Clinician observations and history-taking skills often vary, leading to discrepancies in fatigue evaluations. This study aimed to address these gaps by employing a pendant sensor to remotely identify CRF-associated digital biomarkers through monitoring daily physical activity patterns, postures, and locomotion. While walking speed did not differ between individuals with and without CRF, the pendant sensor effectively distinguished CRF presence based on metrics like light activity percentage, sitting and lying duration, and daily steps in particular longest unbroken walking bout.
Featured Image
Why is it important?
The study highlights the potential for digital health and remote patient monitoring in detecting early cancer related fatigue signs and informing care providers. Future research should investigate the utility of mobility performance monitoring for tracking CRF changes, evaluating intervention responses, and enabling earlier CRF detection.
Perspectives
Read the Original
This page is a summary of: Harnessing digital health to objectively assess cancer-related fatigue: The impact of fatigue on mobility performance, PLoS ONE, February 2021, PLOS,
DOI: 10.1371/journal.pone.0246101.
You can read the full text:
Contributors
The following have contributed to this page